Ignite Creation Date:
2025-12-24 @ 11:20 PM
Ignite Modification Date:
2026-02-09 @ 7:03 AM
Study NCT ID:
NCT06760156
Status:
RECRUITING
Last Update Posted:
2025-12-04
First Post:
2024-12-30
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Tafasitamab and Lenalidomide as First Salvage Therapy for Residual Large B Cell Lym
Sponsor:
H. Lee Moffitt Cancer Center and Research Institute
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Large B-cell Lymphoma | View |
Keywords: